Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-633

6 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 80mg (71610 0633 15)

Bottle Label 80mg (71610 0633 15)
Label for Atorvastatin Calcium USP 80 mg, film-coated tablets. The package contains 15 tablets. Manufactured by Apotex Inc., Toronto, Canada, and repackaged by Aphena Pharma Solutions in Cookeville, TN. The label includes storage information and a barcode with the NDC 71610-0633-15.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence (%) over time in years, comparing Atorvastatin versus Placebo. The graph displays two lines: a solid line for Atorvastatin and a dashed line for Placebo, indicating lower incidence for Atorvastatin. The graph includes a hazard ratio (HR) of 0.64 (0.50-0.83) with a p-value of 0.0005.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph showing cumulative hazard percentage over a 5-year follow-up comparing placebo and atorvastatin. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The atorvastatin line is consistently below the placebo line, with a hazard ratio of 0.63 (0.48-0.83) and p=0.001, indicating a lower cumulative hazard for atorvastatin over time.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. Two lines show the event rates for each dosage, with statistical data indicating a hazard ratio of 0.78 and a significance value of P=0.0002.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including aromatic rings and associated calcium ions, consistent with the active ingredient in ATORVASTATIN CALCIUM tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.